Milae Bioresources Co., Ltd. (KOSDAQ: 218150)

Milae Bioresources Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	15,668	1,992	7,552	18,149	2,811	4,465
Short-Term Investments	9,362	23,262	19,840	9,562	10,136	9,206
Cash & Short-Term Investments	25,030	25,254	27,392	27,711	12,947	13,671
Cash Growth	-7.55%	-7.81%	-1.15%	114.03%	-5.29%	26.09%
Accounts Receivable	11,319	7,386	8,991	8,446	8,699	9,521
Other Receivables	108.94	440.12	251.31	63.25	51.72	92.55
Receivables	11,428	7,826	9,295	8,562	8,766	9,613
Inventory	5,098	4,335	5,116	5,103	3,358	2,687
Prepaid Expenses	8.59	7.33	8.47	7.63	136.22	198.08
Other Current Assets	759.61	512.98	159.93	139.92	105.11	470.72
Total Current Assets	42,324	37,935	41,972	41,524	25,313	26,639
Property, Plant & Equipment	10,962	11,191	11,387	11,436	11,263	11,086
Long-Term Investments	-	-	2.08	498.97	246.78	137.65
Goodwill	1,229	1,229	1,586	1,156	1,156	-
Other Intangible Assets	127.35	178.6	239.66	407.66	481.22	0.45
Long-Term Accounts Receivable	-0	-0	-0	0	0	0
Long-Term Deferred Tax Assets	531.35	483.05	397.91	157.26	435.43	394.29
Other Long-Term Assets	652.57	573.96	510.51	210.88	168.99	260.87
Total Assets	55,826	51,591	56,095	55,390	39,064	38,519
Accounts Payable	3,865	1,980	2,162	3,290	2,437	3,586
Accrued Expenses	203.17	209.53	223.79	185.73	190.81	101.68
Short-Term Debt	4,165	2,686	10,198	2,322	4,424	3,400
Current Portion of Long-Term Debt	545.96	550	550	-	14.16	-
Current Portion of Leases	250.71	194.91	246.56	192.57	122.39	162.35
Current Income Taxes Payable	-	-	123.22	-	63.45	310.28
Other Current Liabilities	1,694	1,506	1,437	1,442	972.1	1,025
Total Current Liabilities	10,724	7,126	14,941	7,432	8,224	8,586
Long-Term Debt	45.54	50	-	14,517	-	-
Long-Term Leases	319.34	237.74	311.38	338.98	151.85	216.19
Other Long-Term Liabilities	9.09	9.01	8.37	42.89	1.06	56
Total Liabilities	11,108	7,430	15,260	22,331	8,377	8,858
Common Stock	2,042	2,042	1,990	1,867	1,867	1,867
Additional Paid-In Capital	22,009	22,009	19,103	12,316	10,809	10,601
Retained Earnings	22,093	21,447	21,019	20,057	18,914	17,964
Treasury Stock	-979.15	-979.15	-979.15	-994.58	-1,041	-774.76
Comprehensive Income & Other	-383.27	-365.24	-387.2	-359.74	-99.99	4.1
Total Common Equity	44,781	44,153	40,745	32,885	30,449	29,661
Minority Interest	-62.89	7.22	89.36	173.98	237.76	-
Shareholders' Equity	44,718	44,160	40,835	33,059	30,687	29,661
Total Liabilities & Equity	55,826	51,591	56,095	55,390	39,064	38,519
Total Debt	5,327	3,719	11,306	17,370	4,712	3,778
Net Cash (Debt)	19,703	21,535	16,086	10,341	8,235	9,893
Net Cash Growth	6.72%	33.88%	55.56%	25.57%	-16.75%	37.87%
Net Cash Per Share	1002.78	1119.39	860.34	583.56	464.46	557.18
Filing Date Shares Outstanding	19.52	19.5	18.98	17.74	17.69	17.79
Total Common Shares Outstanding	19.52	19.5	18.98	17.74	17.69	17.79
Working Capital	31,600	30,809	27,031	34,092	17,089	18,054
Book Value Per Share	2294.30	2264.77	2147.25	1854.08	1720.97	1667.62
Tangible Book Value	43,424	42,745	38,920	31,322	28,813	29,661
Tangible Book Value Per Share	2224.79	2192.55	2051.06	1765.94	1628.46	1667.59
Land	6,107	6,107	6,107	6,107	6,107	5,969
Buildings	4,289	4,289	4,289	4,289	4,289	3,813
Machinery	4,037	3,975	3,760	3,461	3,235	2,902
Construction In Progress	459.77	459.56	234.2	139.81	178.56	178.56

Source: S&P Capital IQ. Standard template. Financial Sources.